Dishman Carbogen Amcis’ wholly owned subsidiary -- Carbogen Amcis AG's manufacturing site in Bubendorf, Switzerland, has successfully completed a routine U.S. Food and Drug Administration (USFDA) inspection. The inspection was concluded without any major or critical observations or Form 483's, thus confirming that no concerns were discovered during the inspection.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
